Trexquant Investment’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.07M Sell
72,344
-84,056
-54% -$1.24M 0.01% 1088
2025
Q1
$2.8M Sell
156,400
-123,817
-44% -$2.22M 0.03% 743
2024
Q4
$4.88M Sell
280,217
-76,491
-21% -$1.33M 0.06% 535
2024
Q3
$4.99M Buy
356,708
+182,220
+104% +$2.55M 0.06% 477
2024
Q2
$1.43M Buy
+174,488
New +$1.43M 0.02% 873
2023
Q3
Sell
-120,990
Closed -$1.86M 1839
2023
Q2
$1.86M Buy
120,990
+46,106
+62% +$708K 0.05% 516
2023
Q1
$1.68M Buy
+74,884
New +$1.68M 0.05% 520
2022
Q4
Sell
-10,579
Closed -$261K 1744
2022
Q3
$261K Sell
10,579
-7,858
-43% -$194K 0.01% 1091
2022
Q2
$447K Sell
18,437
-31,848
-63% -$772K 0.02% 892
2022
Q1
$1.3M Buy
50,285
+40,614
+420% +$1.05M 0.06% 384
2021
Q4
$300K Buy
+9,671
New +$300K 0.02% 921
2021
Q3
Sell
-19,990
Closed -$292K 1502
2021
Q2
$292K Buy
+19,990
New +$292K 0.02% 728
2020
Q4
Sell
-43,711
Closed -$807K 1499
2020
Q3
$807K Buy
43,711
+15,360
+54% +$284K 0.05% 494
2020
Q2
$579K Sell
28,351
-7,277
-20% -$149K 0.04% 615
2020
Q1
$520K Buy
35,628
+11,095
+45% +$162K 0.04% 641
2019
Q4
$348K Buy
24,533
+1,200
+5% +$17K 0.02% 688
2019
Q3
$270K Buy
+23,333
New +$270K 0.02% 650
2019
Q2
Sell
-17,048
Closed -$386K 1133
2019
Q1
$386K Sell
17,048
-12,441
-42% -$282K 0.03% 664
2018
Q4
$667K Buy
+29,489
New +$667K 0.04% 539
2018
Q3
Sell
-10,000
Closed -$273K 1208
2018
Q2
$273K Buy
+10,000
New +$273K 0.02% 708
2017
Q4
Sell
-8,154
Closed -$203K 1261
2017
Q3
$203K Buy
+8,154
New +$203K 0.05% 635
2016
Q2
Sell
-16,332
Closed -$223K 1114
2016
Q1
$223K Sell
16,332
-24,068
-60% -$329K 0.03% 817
2015
Q4
$779K Buy
40,400
+22,700
+128% +$438K 0.07% 496
2015
Q3
$358K Sell
17,700
-19,100
-52% -$386K 0.03% 830
2015
Q2
$1.22M Buy
+36,800
New +$1.22M 0.14% 259
2015
Q1
Sell
-14,670
Closed -$179K 1199
2014
Q4
$179K Buy
+14,670
New +$179K 0.03% 823